The KRT5 Knockout AGS Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population derived from the AGS human gastric adenocarcinoma epithelial cell line, featuring targeted disruption of the KRT5 gene. This loss-of-function model is designed to facilitate detailed investigations into keratin 5-dependent cellular processes without presupposing complete gene ablation or clonal homogeneity. The polyclonal format retains genetic heterogeneity inherent to the edited pool, enabling researchers to assess population-level responses to KRT5 disruption. The cells are provided as a ready-to-use tool for applications ranging from cytoskeletal biology to cancer cell behavior.
AGS cells, the host background, originate from a female patient diagnosed with diffuse-type gastric adenocarcinoma and are characterized by an adherent epithelial morphology. This well-established cell line is widely employed as a model system for diffuse-type gastric cancer, recapitulating key features of tumor cell adhesion, migration, and invasiveness. Its epithelial nature makes it particularly suitable for probing the roles of intermediate filament proteins in maintaining tissue architecture and mechanical resilience. The AGS line??s genetic and phenotypic fidelity to the primary disease context provides a robust platform for functional genomics studies in gastric adenocarcinomas.
KRT5 encodes keratin 5, a type II intermediate filament protein that obligatorily assembles with keratin 14 (KRT14) to form heterodimeric filaments essential for epithelial cell structural integrity. Within the mechanistic framework, KRT5 is transcriptionally activated by TP63 and regulated by upstream cues including JUN, FOS, TGFB1, and EGF signals. In turn, KRT5-containing filaments interact with desmosomal components??such as desmoplakin (DSP), junction plakoglobin (JUP), plakophilin-1 (PKP1), and the cytolinker plectin (PLEC)??to anchor at desmosomes and integrin-based adhesions. Downstream, KRT5 loss influences cytoskeletal reorganization, cell mechanics, focal adhesion dynamics, and expression of epithelial-mesenchymal transition (EMT) markers, thereby modulating cellular cohesion and migratory capacity.
In the AGS gastric adenocarcinoma context, targeted KRT5 disruption holds particular significance for deciphering the molecular underpinnings of diffuse-type gastric cancer progression. As keratin filaments are critical for withstanding mechanical stress, their perturbation can compromise epithelial barrier function and promote a more invasive phenotype. By abolishing KRT5 expression, this model enables dissection of how keratin network disassembly impacts AGS cell adhesion, migration, and EMT??processes intimately linked to metastasis and drug resistance. Consequently, the knockout cells serve as a valuable in vitro surrogate for examining how intermediate filament alterations contribute to gastric cancer aggressiveness.
Key research applications include functional studies of the keratin cytoskeleton, quantitative assessment of gastric cancer cell migration and invasion using scratch wound healing and transwell assays, and investigation of EMT markers via RT-qPCR and western blotting (e.g., for KRT5/KRT14). The model is also suitable for immunofluorescence visualization of filament architecture, cell adhesion assays, MTT viability testing, and drug resistance mechanism elucidation. Researchers can pair these cells with wild-type AGS controls to dissect KRT5-dependent signaling in wound healing and cytoskeletal organization. For further information, contact Ascent Research.
